Barclays’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.81M Sell
191,731
-42,729
-18% -$1.52M ﹤0.01% 1390
2025
Q1
$7.96M Buy
234,460
+107,889
+85% +$3.66M ﹤0.01% 1147
2024
Q4
$4.12M Sell
126,571
-33,779
-21% -$1.1M ﹤0.01% 1740
2024
Q3
$7.81M Sell
160,350
-35,663
-18% -$1.74M ﹤0.01% 1186
2024
Q2
$8.68M Sell
196,013
-10,494
-5% -$465K ﹤0.01% 952
2024
Q1
$11.6M Buy
206,507
+19,122
+10% +$1.07M ﹤0.01% 947
2023
Q4
$11.3M Sell
187,385
-93,709
-33% -$5.64M ﹤0.01% 995
2023
Q3
$18.9M Buy
281,094
+197,357
+236% +$13.3M 0.01% 688
2023
Q2
$5.78M Sell
83,737
-139,801
-63% -$9.65M ﹤0.01% 1151
2023
Q1
$10.8M Sell
223,538
-248,716
-53% -$12M ﹤0.01% 782
2022
Q4
$23.6M Buy
472,254
+171,042
+57% +$8.54M 0.01% 593
2022
Q3
$12.3M Buy
301,212
+8,300
+3% +$339K 0.01% 757
2022
Q2
$16.1M Buy
292,912
+47,586
+19% +$2.62M 0.01% 660
2022
Q1
$8.92M Buy
+245,326
New +$8.92M 0.01% 905